Novel Homozygous Pathogenic Mutations of LAMA 2 Gene in patients with congenital muscular dystrophy
Iranian Journal of Child Neurology,
Vol. 15 No. 1 (2021),
1 January 2021
,
Page 101-106
https://doi.org/10.22037/ijcn.v15i1.21649
Abstract
The laminin-α2 subunit is a protein that is encoded by the Laminin α 2 gene (LAMA2) which has the role of adhesion (attachment of cells to one another). Genetics consideration showed that mutation in LAMA2 caused a collection of muscle-wasting conditions called Muscular Dystrophy (MD). This disorder causes disconnection of the muscular cells and degeneration of the musculoskeletal system. In this study, we define the molecular consideration of 3 patients with laminin α 2 deficiency by clinical presentations of congenital muscular dystrophy (CMD). In this regard, 65 exons of LAMA2 gene were amplified by Polymerase Chain Reaction (PCR). Also, MLPA and NGS was done for all patients. Because of negativity of NGS, the gene sequence was performed. The results of searching for rearrangements of the LAMA2 gene enabled us to recognize homozygous pathogenic mutations c.2049_c.2050del, c.7156-2A>G and c,1303C>T. These mutations produce an out-of-frame transcript that will be degraded by nonsense-mediated decay. Therefore, we think these changes are pathogenic ones.
- LAMA-2
- DMC1A
- Muscular dystrophy
How to Cite
References
Yurchenco PD, McKee KK, Reinhard JR, Rüegg MA. Laminin-deficient muscular dystrophy: Molecular pathogenesis and structural repair strategies. Matrix Biology. 2017: 174-187.
Quijano-Roy S, Sparks SE, Rutkowski A. LAMA2-related muscular dystrophy. 2012.
Oliveira J, Santos R, Soares‐Silva I, Jorge P, Vieira E, Oliveira M, et al. LAMA2 gene analysis in a cohort of 26 congenital muscular dystrophy patients. Clinical genetics. 2008;74(6):502-12.
Pini A, Merlini L, Tome FM, Chevallay M, Gobbi G. Merosin-negative congenital muscular dystrophy, occipital epilepsy with periodic spasms and focal cortical dysplasia. Report of three Italian cases in two families. Brain and Development. 1996;18(4):316-22.
Helbling-Leclerc A, Zhang X, Topaloglu H, Cruaud C, Tesson F, Weissenbach J, et al. Mutations in the laminin α2–chain gene (LAMA2) cause merosin–deficient congenital muscular dystrophy. Nature genetics. 1995;11(2):216.
Sakane I, Kamataki C, Takizawa Y, Nakashima M, Toki S, Ichikawa H, et al. Filament formation and robust strand exchange activities of the rice DMC1A and DMC1B proteins. Nucleic acids research. 2008;36(13):4266-76.
Lee JY, Terakawa T, Qi Z, Steinfeld JB, Redding S, Kwon Y, et al. Base triplet stepping by the Rad51/RecA family of recombinases. Science. 2015;349(6251):977-81.
Hayashi YK, Tezak Z, Momoi T, Nonaka I, Garcia CA, Hoffman EP, et al. Massive muscle cell degeneration in the early stage of merosin-deficient congenital muscular dystrophy. Neuromuscular Disorders. 2001;11(4):350-9.
Di Blasi C, Piga D, Brioschi P, Moroni I, Pini A, Ruggieri A, et al. LAMA2 gene analysis in congenital muscular dystrophy: new mutations, prenatal diagnosis, and founder effect. Archives of neurology. 2005;62(10):1582-6.
Jahangirian E, Mohammadpour A, Lamsoo AMS, Mofrad HT, Ramedani B, Farjami Z. Relation between DISC1 gene rs3738401 Polymorphism in Iranian Patients affected by Bipolar Disorder. Advances in Bioresearch. 2015;6(2).
Jahangirian E, Ramedani B, Akhavan S, Mofrad HT, Farjami Z. Evaluation of DISC1 gene rs3738401 polymorphism in Iranian Multiple sclerosis (MS) patients affected by with type 2 Diabetes. Advances in Bioresearch. 2016;7(5).
Nelson I, Stojkovic T, Allamand V, Leturcq F, Bécane H-M, Babuty D, et al. Laminin α2 deficiency-related muscular dystrophy mimicking Emery-Dreifuss and collagen VI related diseases. Journal of neuromuscular diseases. 2015;2(3):229-40.
Zhang X, Vuolteenaho R, Tryggvason K. Structure of the human laminin α2-chain gene (LAMA2), which is affected in congenital muscular dystrophy. Journal of Biological Chemistry. 1996;271(44):27664-9.
Simon MM, Moresco EMY, Bull KR, Kumar S, Mallon A-M, Beutler B, et al. Current strategies for mutation detection in phenotype-driven screens utilising next generation sequencing. Mammalian Genome. 2015;26(9-10):486-500.
He Z, Luo X, Liang L, Li P, Li D, Zhe M. Merosin-deficient congenital muscular dystrophy type 1A: A case report. Experimental and therapeutic medicine. 2013;6(5):1233-6.
Harris E, McEntagart M, Topf A, Lochmüller H, Bushby K, Sewry C, et al. Clinical and neuroimaging findings in two brothers with limb girdle muscular dystrophy due to LAMA2 mutations. Neuromuscular Disorders. 2017;27(2):170-4.
O'grady GL, Lek M, Lamande SR, Waddell L, Oates EC, Punetha J, et al. Diagnosis and etiology of congenital muscular dystrophy: We are halfway there. Annals of neurology. 2016;80(1):101-11.
Ghaoui R, Cooper ST, Lek M, Jones K, Corbett A, Reddel SW, et al. Use of whole-exome sequencing for diagnosis of limb-girdle muscular dystrophy: outcomes and lessons learned. JAMA neurology. 2015;72(12):1424-32.
- Abstract Viewed: 457 times